Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)
Download: Excel (XLSX), Comma-separated (CSV)
Cell line | Drug name | Experimental replicate | Timepoint | Drug concentration | Live cell count | Average live cell count, DMSO control | Average live cell count (time = 0) | Log10(drug concentration) | GR value | Relative cell count (treatment versus DMSO) | Cell doublings (DMSO control) | Experiment name |
---|---|---|---|---|---|---|---|---|---|---|---|---|
HCC38 | Buparlisib | 2 | 72 | 1.0 | 1471.0 | 3048.5 | 690.5 | 0.0 | 0.423 | 0.483 | 2.142 | HCC38 BKM120 0 2 72 |
HCC38 | Buparlisib | 2 | 72 | 0.032 | 3141.0 | 3048.5 | 690.5 | -1.49 | 1.030 | 1.030 | 2.142 | HCC38 BKM120 0 2 72 |
HCC38 | Buparlisib | 2 | 72 | 0.1 | 2958.8 | 3048.5 | 690.5 | -1.0 | 0.972 | 0.971 | 2.142 | HCC38 BKM120 0 2 72 |
HCC38 | Buparlisib | 2 | 72 | 0.32 | 2663.3 | 3048.5 | 690.5 | -0.495 | 0.878 | 0.874 | 2.142 | HCC38 BKM120 0 2 72 |
HCC38 | WYE-125132 | 2 | 72 | 1.0 | 985.5 | 3050.0 | 690.5 | 0.0 | 0.181 | 0.323 | 2.143 | HCC38 WYE125132 0 2 72 |
HCC38 | WYE-125132 | 2 | 72 | 0.01 | 2479.3 | 3050.0 | 690.5 | -2.0 | 0.816 | 0.813 | 2.143 | HCC38 WYE125132 0 2 72 |
HCC38 | WYE-125132 | 2 | 72 | 0.032 | 1949.0 | 3050.0 | 690.5 | -1.49 | 0.623 | 0.639 | 2.143 | HCC38 WYE125132 0 2 72 |
HCC38 | WYE-125132 | 2 | 72 | 0.1 | 1414.8 | 3050.0 | 690.5 | -1.0 | 0.398 | 0.464 | 2.143 | HCC38 WYE125132 0 2 72 |
HCC38 | WYE-125132 | 2 | 72 | 3.2 | 929.8 | 3050.0 | 690.5 | 0.505 | 0.149 | 0.305 | 2.143 | HCC38 WYE125132 0 2 72 |
HCC38 | WYE-125132 | 2 | 72 | 0.32 | 1061.0 | 3050.0 | 690.5 | -0.495 | 0.222 | 0.348 | 2.143 | HCC38 WYE125132 0 2 72 |
HCC38 | WYE-125132 | 2 | 72 | 0.001 | 2871.8 | 3050.0 | 690.5 | -3.0 | 0.945 | 0.942 | 2.143 | HCC38 WYE125132 0 2 72 |
HCC38 | WYE-125132 | 2 | 72 | 0.0032 | 2749.3 | 3050.0 | 690.5 | -2.49 | 0.905 | 0.901 | 2.143 | HCC38 WYE125132 0 2 72 |
HCC38 | CAL-101 | 2 | 72 | 1.0 | 2843.0 | 3073.0 | 690.5 | 0.0 | 0.929 | 0.925 | 2.154 | HCC38 CAL101 0 2 72 |
HCC38 | CAL-101 | 2 | 72 | 0.001 | 3075.8 | 3073.0 | 690.5 | -3.0 | 1.000 | 1.000 | 2.154 | HCC38 CAL101 0 2 72 |
HCC38 | CAL-101 | 2 | 72 | 0.32 | 3061.5 | 3073.0 | 690.5 | -0.495 | 0.997 | 0.996 | 2.154 | HCC38 CAL101 0 2 72 |
HCC38 | CAL-101 | 2 | 72 | 0.0032 | 3088.8 | 3073.0 | 690.5 | -2.49 | 1.000 | 1.010 | 2.154 | HCC38 CAL101 0 2 72 |
HCC38 | CAL-101 | 2 | 72 | 0.032 | 3149.8 | 3073.0 | 690.5 | -1.49 | 1.020 | 1.020 | 2.154 | HCC38 CAL101 0 2 72 |
HCC38 | CAL-101 | 2 | 72 | 3.2 | 2692.3 | 3073.0 | 690.5 | 0.505 | 0.881 | 0.876 | 2.154 | HCC38 CAL101 0 2 72 |
HCC38 | CAL-101 | 2 | 72 | 0.1 | 3062.0 | 3073.0 | 690.5 | -1.0 | 0.997 | 0.996 | 2.154 | HCC38 CAL101 0 2 72 |
HCC38 | CAL-101 | 2 | 72 | 0.01 | 2962.3 | 3073.0 | 690.5 | -2.0 | 0.966 | 0.964 | 2.154 | HCC38 CAL101 0 2 72 |
HCC38 | PIK-93 | 3 | 72 | 3.2 | 2257.8 | 3077.8 | 1180.5 | 0.505 | 0.598 | 0.734 | 1.382 | HCC38 PIK93 0 3 72 |
HCC38 | PIK-93 | 3 | 72 | 0.032 | 3023.8 | 3077.8 | 1180.5 | -1.49 | 0.975 | 0.982 | 1.382 | HCC38 PIK93 0 3 72 |
HCC38 | PIK-93 | 3 | 72 | 0.1 | 3135.5 | 3077.8 | 1180.5 | -1.0 | 1.030 | 1.020 | 1.382 | HCC38 PIK93 0 3 72 |
HCC38 | PIK-93 | 3 | 72 | 0.32 | 3011.8 | 3077.8 | 1180.5 | -0.495 | 0.969 | 0.979 | 1.382 | HCC38 PIK93 0 3 72 |
HCC38 | PIK-93 | 3 | 72 | 0.01 | 2884.0 | 3077.8 | 1180.5 | -2.0 | 0.908 | 0.937 | 1.382 | HCC38 PIK93 0 3 72 |